Artesunate plus sulfadoxine-pyrimethamine for uncomplicated malaria in Kenyan children: A randomized, double-blind, placebo-controlled trial

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 97, Issue 5, 2003, Pages 585-591

  Obonyo, Charles O ^a   Ochieng, Francis ^b   Taylor W R J , Walter R J ^c   Ochola, Samuel A ^d   Mugitu, Kefas ^e   Olliaro, Piero ^c   ter Kuile, Feiko ^a,f   Oloo, Aggrey J ^a  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b Siaya District Hospital   (Kenya)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d MINISTRY OF HEALTH   (Kenya)

^e IFAKARA HEALTH INSTITUTE   (Tanzania)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Artesunate; Combination therapy; Kenya; Malaria; Sulfadoxine pyrimethamine

Indexed keywords

ARTESUNATE; FANSIDAR; PLACEBO; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; PYRIMETHAMINE; SESQUITERPENE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG TOLERABILITY; DRUG UTILIZATION; FEMALE; GAMETOCYTE; HUMAN; KENYA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PUBLIC HOSPITAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TREATMENT FAILURE; TREATMENT OUTCOME; VOMITING; BLOOD; DRUG COMBINATION; FEVER; GENOTYPE; INFANT; NEWBORN;

ARTESUNATE; PLASMODIUM FALCIPARUM;

ANTIMALARIALS; ARTEMISININS; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; FEVER; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; KENYA; MALARIA, FALCIPARUM; MALE; PYRIMETHAMINE; SESQUITERPENES; SULFADOXINE; TREATMENT OUTCOME;

EID: 7244227837     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(03)80038-X     Document Type: Article

References (30)

1. Amukoye E. Winstanley P.A. Watkins W.M. Snow R.W. Hatcher J. Mosobo M. Ngumbao E. Lowe B. Ton M. Minyiri G. Marsh K. Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria Antimicrobial Agents and Chemotherapy 41 1997 2261-2264
2. Anabwani G.M. Esamai F.O. Menya D.A. A randomized controlled trial to assess the relative efficacy of chloroquine, amodiaquine, halofantrine and Fansidar in the treatment of uncomplicated malaria in children East African Medical Journal 73 1996 155-158
3. Beier J. Oster C.N. Onyango F.K. Bales J.D. Sherwood J.A. Perkins P.V. Chumo D.K. Koech D.K. Whitmire R.E. Roberts C.R. Diggs C.L. Hoffman S.L. Plasmodium falciparum incidence relative to entomological inoculation rates at a site proposed for testing malaria vaccines in western Kenya American Journal of Tropical Medicine and Hygiene 50 1994 529-536
4. Bijl H. Kager J. Koetsier D.W. van der Werf T.S. Chloroquine and sulfadoxine-pyrimethamineresistant falciparum malaria in vivo - a pilot study in rural Zambia Tropical Medicine and International Health 5 2000 692-695
5. Bloland P.B. Ettling M. Making malaria-treatment policy in the face of drug resistance Annals of Tropical Medicine and Parasitology 93 1999 5-23
6. Bloland P.B. Lackritz E.M. Kazembe P.N. Were J.B.O. Steketee R. Campbell C.C. Beyond chloroquine: Implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa Journal of Infectious Diseases 167 1993 932-937
7. Duraisingh M.T. Curtis J. Warhurst D.C. Plasmodium falciparum: Detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion Experimental Parasitology 89 1998 1-8
8. Edwards I.R. Aronson J.K. Adverse drug reactions: Definitions, diagnosis, and management Lancet 356 2000 1255-1259
9. Fevre E.M. Barnish G. Malaria-treatment policies: When and how should they be changed? Annals of Tropical Medicine and Parasitology 93 1999 549-560
10. Gorissen E. Ashruf G. Lamboo M. Bennebroek J. Gikunda S. Mbaruku G. Kager P.A. In vivo efficacy of amodiaquine and sulfadoxine/pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania Tropical Medicine and International Health 5 2000 459-463
11. Grosser J. Bacteriologic basis of short-course chemotherapy for tuberculosis Clinics in Chest Medicine 1 1980 231-234
12. Handunnetti S.M. Gunewardena D.M. Pathirana P.P.S.L. Ekanayake K. Weerasinghe S. Mendis K.N. Features of recrudescent chloroquine-resistant Plasmodium falciparum infections confer a survival advantage on parasites and have implications for disease control Transactions of the Royal Society of Tropical Medicine and Hygiene 90 1996 563-567
13. Hastings I.M. Watkins W.M. White N.J. The evolution of drug-resistant malaria: The role of drug-elimination half-life Philosophical Transactions of the Royal Society of London, Series B, Biological Sciences 357 2002 505-519
14. Kamya M.R. Dorsey G. Gasasira A. Ndeezi G. Babirye J.N. Staedke S.G. Rosenthal P.J. The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda Transactions of the Royal Society of Tropical Medicine and Hygiene 90 2001 563-567
15. Nosten F. van Vugt M. Price R. Luxemburger C. Thway K.L. Brockman A. McGready R. ter Kuile F.O. Looareesuwan S. White N.J. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: A prospective study Lancet 356 2000 297-302
16. Nzila A.M. Nduati E. Mberu E.K. Sibley C.H. Monks S.A. Winstanley P.A. Watkins W.M. Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethamine/ sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum Journal of Infectious Diseases 181 2000 2023-2028
17. Ogutu B.R. Smoak B.L. Nduati R.W. Mbori-Ngacha D.A. Mwathe F. Shanks G.D. The efficacy of pyrimethamine-sulfadoxine (Fansidar) in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children Transactions of the Royal Society of Tropical Medicine and Hygiene 94 2000 83-84
18. Price R. Nosten F. Luxemburger C. ter Kuile F.O. Phaipun L. Chongsuphajaisiddhi T. White N.J. Effects of artemisinin derivatives on malaria transmissibility Lancet 347 1996 1654-1658
19. Ronn A. Msangeni H. Mhia J. Wernsdorfer W. Bygberg I. High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania Transactions of the Royal Society of Tropical Medicine and Hygiene 90 1996 179-181
20. Sibley C.H. Hyde J.E. Sims P.F.G. Plowe C.V. Kublin J.G. Mberu E.K. Cowman A.F. Winstanley P.A. Watkins W.M. Nzila A.M. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: What next? Trends in Parasitology 17 2001 582-588
21. Snounou G. Beck H. The use of PCR genotyping in the assessment of recrudescence or reinfection after anti-malarial drug treatment Parasitology Today 14 1998 462-467
22. Tjitra E. Suprianto S. Currie B.J. Morris P.S. Saunders J.R. Anstey N.M. Therapy of uncomplicated falciparum malaria: A randomized trial comparing artesunate plus sulfadoxine-pyrimethamine versus sulfadoxinepyrimethaminealone in Irian Java, Indonesia American Journal of Tropical Medicine and Hygiene 65 2001 309-317
23. van Dillen J. Custers M. Wensink A. Wouters B. van Voorhuizen T. Voorn W. Khan B. Muller L. Nevill C. A comparison of amodiaquine and sulfadoxinepyrimethamine as first-line treatment of falciparum malaria in Kenya Transactions of the Royal Society of Tropical Medicine and Hygiene 93 1999 185-188
24. von Seidlein L. Milligan P. Pinder M. Bojang K. Anyalebechi C. Gosling R. Coleman R. Ude J.I. Sadiq A. Duraisingh M. Warhurst D. Alloueche A. Targett G. McAdam K. Greenwood B.M. Walraven G. Olliaro P. Doherty T. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: A double blind, randomized, controlled trial Lancet 355 2000 352-357
25. Warsame M. Kilimali V.A.E.B. Wernsdorfer W.H. Lebbad M. Rutta A.S. Ericsson O. Resistance to chloroquine and sulfadoxine-pyrimethamine in Plasmodium falciparum in Muheza district, Tanzania Transactions of the Royal Society of Tropical Medicine and Hygiene 93 1999 312-313
26. Watkins W.M. Mosobo M. Treatment of Plasmodium falciparum malaria with pyrimethamine and sulfadoxine: A selective pressure for resistance is a function of long elimination half-life Transactions of the Royal Society of Tropical Medicine and Hygiene 87 1993 75-79
27. White N.J. Antimalarial drug resistance and combination chemotherapy Philosophical Transactions of the Royal Society of London, Series B 354 1999 739-749
28. White N.J. Olliaro P.L. Strategies for the prevention of antimalarial drug resistance: Rationale for combination therapy for malaria Parasitology Today 12 1996 399-401
29. WHO Severe and complicated malaria 2nd edition Transactions of the Royal Society of Tropical Medicine and Hygiene 84 1990 supplement 2
30. WHO/CDS/RBM/2001.35 WHO Antimalarial Drug Combination Therapy. Report of a WHO Technical Consultation 2001 World Health Organization Geneva